Biotechnology
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032
Revenue, 2024 (USD Million)
1,762.75
Forecast, 2032 (USD Million)
10,355.40
CAGR, 2024 - 2032
23.66%
Report Coverage
Global
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market 2018-2032 USD Million
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market, Overview (2024-2032)
Market Growth and Projections:
- Market Size (2024): 1,762.75 USD Million
- Projected Market Size (2032): 10,355.40 USD Million
- CAGR (2024-2032): 23.66%
Key Findings of Global Circulating Tumor Cells (CTC) Liquid Biopsy Market
- The Global Circulating Tumor Cells (CTC) Liquid Biopsy Market is likely to grow at a CAGR of 23.66% during the forecast period of 2024 to 2032.
- Global Circulating Tumor Cells (CTC) Liquid Biopsy Marketsize was valued at 1,762.75 USD Million in 2024.
- In 2024, Research & Academic Institutes segment dominated the market with the largest market share.
- CTC Detection Methods in the product segment is expected to witness the fastest growth during the forecast period.
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Scope
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Segmentation & Scope
Technology
- Immunocytochemical Technologies
- Negative Selection
- Single Spiral Microchannel
- Microchips
- Xenotransplantation Models
- Functional In vitro Cell Invasion Assay
- Molecular (RNA)-Based Technologies
- Ex Vivo Positive Selection
- CTC Enrichment Methods
- CTC Detection Methods
Application
- Multiple Chromosome Abnormalities
- Cancer Stem Cell Research
- Others
End User
- Physician Laboratories
- Hospitals
- Reference Laboratories
- Research & Academic Institutes
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 1,762.75 USD Million |
| Market Value in 2032 | 10,355.40 USD Million |
| CAGR (2024-2032) | 23.66% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Technology,Application,End User |
| Largest Segment | Research & Academic Institutes |
| Fastest Growing Segment | CTC Detection Methods |
| Major Players | Myriad Genetics, Inc., Natera, Inc., Illumina, Inc., Immucor, Thermo Fisher Scientific Inc., QIAGEN, Biolidics Limited, Bio-Rad Laboratories, Inc., Biocept, Inc., FOUNDATION MEDICINE, INC., Guardant Health, Eurofins Genomics, F. Hoffmann-La Roche Ltd., Others |
Market Segmentation:
-
Product Segment:
- Largest Segment (2024): Research & Academic Institutes
- Fastest Growing Segment (2024-2032): CTC Detection Methods
Regional Insights:
-
Leading Market (2024-2032): Global
- Key Country: U.S., leading in terms of revenue and market share by 2032.
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Company Share Analysis
| Name | Market Share | OwnnerShip | HQ | Website |
|---|---|---|---|---|
| Myriad Genetics | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Inc. | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Natera | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Inc. | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Illumina | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Inc. | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Immucor | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Thermo Fisher Scientific Inc. | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| QIAGEN | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Biolidics Limited | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Bio-Rad Laboratories | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Inc. | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Biocept | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Inc. | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| FOUNDATION MEDICINE | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| INC. | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Guardant Health | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Eurofins Genomics | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| F. Hoffmann-La Roche Ltd. | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Others | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Geographical Sales Distribution, 2018-2032 USD Million
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Company Profiling
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | www.molnlycke.com |
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | www.molnlycke.com |
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | www.molnlycke.com |
Frequently Asked Questions
The Global Circulating Tumor Cells (CTC) Liquid Biopsy Market is segmented based on Segmentation Technology,Application,End User.
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market was valued at USD 1,762.75(Revenue in USD Million) in 2020.
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market is projected to grow at a CAGR of 23.66% during the forecast period of 2024 to 2032.
The estimated market value of the Global Circulating Tumor Cells (CTC) Liquid Biopsy Market for final year is USD 10,355.40 (USD Million).
Related Markets
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.
